What Is Cerebral Palsy (CP)
Cerebral palsy (CP) is a group of developmental and functional disorders of the central nervous system that result from damage to a child's brain during its early stages of formation. The main causes of cerebral palsy include oxygen deprivation during pregnancy, childbirth, or the first days of life, as well as infections, injuries, and genetic factors.
Symptoms of cerebral palsy can range from mild muscle weakness to severe movement disorders. Children with this diagnosis typically experience:
- Movement disorders (such as spasticity, dystonia, or ataxia).
- Difficulty with movement coordination and balance.
- Possible co-occurring issues, such as problems with speech, hearing, vision, and cognitive development.
While no medication can fully cure cerebral palsy, modern treatment approaches aim to improve a child's quality of life, develop functional abilities, and reduce symptoms. One such method is stem cell therapy, which shows strong potential in the rehabilitation of children with cerebral palsy.
Umbilical Cord Blood Stem Cells: What They Are and How They Work
Stem cells are unique cells in the body capable of transforming into various cell and tissue types. They play a key role in repairing and regenerating damaged tissue. Umbilical cord blood, which remains in the placenta and umbilical cord after a baby is born, is a rich source of hematopoietic and mesenchymal stem cells (MSCs).
Stem cell therapy for cerebral palsy is based on their ability to:
- Reduce inflammation: Inflammatory processes in the brain often worsen the damage associated with cerebral palsy. Stem cells reduce inflammation, creating favorable conditions for tissue repair.
- Stimulate regeneration: They help form new blood vessels, nerve cells, and other structures needed for normal brain function.
- Provide neuroprotection: Stem cells protect existing neurons from further damage
For parents of children with special needs, using mesenchymal stem cells (MSCs) from umbilical cord tissue is becoming a promising solution for treating various conditions, including those involving damage to the nervous system and other tissues.
Why Umbilical Cord Blood Mesenchymal Cells Are Considered Safe and Effective:
1. Safe and ethically acceptable collection: The umbilical cord is typically considered medical waste after birth, allowing it to be used without surgery or risky procedures for mother or child. Collecting cord-derived MSCs causes no pain and doesn't face the ethical concerns that exist, for example, with embryonic stem cells.
2. Multipotency and self-renewal: Cord-derived MSCs can differentiate into various cell types, including osteocytes (bone cells), chondrocytes (cartilage cells), and neurons (nerve cells). Their capacity for self-renewal and multipotency makes them suitable for treating and regenerating tissue in disorders such as cerebral palsy and brain injury.
3. High recovery and expansion rate: Research shows that cord-derived MSCs can expand rapidly in laboratory culture, making it possible to obtain a large number of cells for various therapies. This is especially important for patients who require a significant volume of cellular material, such as in cases of extensive tissue damage.
4. Immunomodulatory properties and low rejection risk: One of the most significant advantages of cord-derived MSCs is their low immunogenicity, which allows them to be used for allogeneic (donor) treatment. These cells have immunomodulatory properties that help reduce inflammatory processes and regulate immune system activity, preventing an excessive immune response and reducing the risk of rejection. This effect is achieved through the cells' ability to release specific molecules, such as PGE2 and HLA-G5, that suppress immune cell activity.
5. Clinical trials and progress in regenerative medicine: Today, cord-derived MSCs are being actively studied for use in various conditions, such as autism, cerebral palsy, and even degenerative diseases like liver disease and cardiovascular conditions. Recent studies have shown that cord-derived MSCs help improve organ function, support the repair of nerve and tissue damage, and reduce inflammatory responses. Clinical studies in particular confirm that cord-derived MSCs can improve outcomes for children with cerebral palsy by supporting nerve tissue regeneration and improving cognitive function.
6. No risk of teratomas: Unlike embryonic stem cells, using cord-derived MSCs carries no risk of teratoma (tumor) formation, making them a safer option for clinical use.
7. Methods of cell isolation and expansion: In practice, cells can be obtained from various parts of the umbilical cord, including Wharton's jelly (the main source of MSCs), the blood vessels, and the subepithelial layer. Several methods exist for isolating cells, such as enzymatic digestion and the explant method, allowing cells to be further expanded for use in therapy.
8. Low senescence and a youthful phenotype: Cord-derived MSCs are less prone to aging compared to cells from other sources, such as bone marrow, which increases their potential for long-term use.
A recently published study offers new possibilities for treating cerebral palsy (CP) using mesenchymal stem cells (MSCs) derived from umbilical cord tissue.
The study looked at 4 children with severe cerebral palsy who couldn't stand or walk on their own. They underwent six rounds of allogeneic MSC therapy, with cells administered intranasally, intravenously, and intramuscularly.
Key Findings:
Reduced spasticity — According to the results, all patients showed a significant reduction in muscle spasticity, as measured by the Modified Ashworth Scale. This effect was observed as early as two months after starting therapy and persisted for a year.
2. Improved motor function — According to the Gross Motor Function Classification System (GMFCS) and the Manual Ability Classification System (MACS), improvements in motor function were observed 12 months after treatment, though statistically significant changes only appeared by the end of the year.
3. Cognitive function — No significant improvements in cognitive ability were observed during the follow-up period.
How Do MSCs Work?
MSCs demonstrate their effectiveness through several key mechanisms: anti-inflammatory action, neuroprotection, and neuroregeneration. The cells migrate to the site of brain damage, where they activate repair processes, including growth factor production and reduced inflammatory responses. Paracrine effects are also observed, which enhance local regenerative processes.
Are There Any Side Effects?
The study showed minimal side effects, including a brief rise in body temperature and mild pain at the injection site. No more serious complications were recorded, confirming the safety of using MSCs in this context.
Therapy using umbilical cord mesenchymal cells appears to be a promising alternative for treating cerebral palsy, particularly for reducing spasticity and partially restoring motor function.
Safety of Umbilical Cord Blood Stem Cell Therapy
One of the key questions for parents is the safety of this treatment method. Research and clinical practice show that using umbilical cord blood stem cells is safe when all medical standards are followed.
Why Is the Therapy Safe?
- No rejection risk: Umbilical cord blood used is most often the patient's own (autologous) or from a compatible donor, minimizing the risk of immune reactions.
- Certification and quality control: Before use, the cells undergo strict screening for infectious agents, genetic defects, and compliance with medical standards.
- Minimal side effects: According to numerous clinical studies, side effects (such as fever or brief malaise) are extremely rare and pose no threat to the child's life.
Effectiveness of Stem Cell Therapy for Cerebral Palsy
Scientific research confirms that umbilical cord blood stem cell therapy helps improve outcomes for children with cerebral palsy. Here's the main evidence for the method's effectiveness:
- Improved motor function: Studies have shown that children who completed a course of treatment performed better on mobility and coordination tests.
- Cognitive development: Some patients reported improvements in speech, memory, and attention span.
- Overall rehabilitation progress: Combined with other methods (physiotherapy, exercise therapy, speech therapy), stem cell therapy significantly speeds up the rehabilitation process.
How the Procedure Works
The treatment process includes several stages:
- Cell collection: For autologous therapy, cells are collected from the child's umbilical cord blood right after birth and frozen for future use.
- Patient preparation: Diagnostic procedures are carried out to assess the child's condition and rule out any contraindications.
- Cell administration: Stem cells are administered intravenously or directly into the affected areas, ensuring they quickly reach the brain.
